Engineering Complexity with Precision: Designing Next-Generation Bispecific ADCs for Solid Tumour Impact
- Moving beyond binary gating: Fine-tuned molecular engineering of bispecific ADCs novel synergy between targets to achieve precise and effective cancer treatment
- Leveraging modular platforms for generation of complex biologics (including bispecific ADCs) to control geometry, valency, and site-specific conjugation, enabling unbiased hypothesis generation and rapid prototyping of complex drug candidates
- Advancing solid tumour programs while remaining adaptable to emerging indications and modalities